Dopamine Oxidation and Autophagy
暂无分享,去创建一个
J. Segura-Aguilar | Juan Segura-Aguilar | Patricia Muñoz | Irmgard Paris | I. Paris | Patricia Muñoz | Sandro Huenchuguala | Sandro Huenchuguala
[1] Peter T. Lansbury,et al. Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.
[2] K. Vrana,et al. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase , 1998, Journal of neuroscience research.
[3] S. Tooze,et al. Microtubules Facilitate Autophagosome Formation and Fusion of Autophagosomes with Endosomes , 2006, Traffic.
[4] R. Mayeux,et al. Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.
[5] R. Coccia,et al. Catecholamines oxidation by xanthine oxidase. , 1997, Biochimica et biophysica acta.
[6] D. Graham,et al. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.
[7] L. Chia,et al. Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease , 2005, Journal of Neural Transmission.
[8] David Park,et al. Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy , 2009, PloS one.
[9] S. Vatner,et al. Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion , 2008, Autophagy.
[10] G. Miller,et al. Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons , 2009, Molecular Neurobiology.
[11] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[12] J. Shih,et al. Molecular Biology of Monoamine Oxidase A and B: Their Role in the Degradation of Serotonin , 2000 .
[13] J. Segura-Aguilar,et al. Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line--an experimental cell model for dopamine toxicity studies. , 2007, Chemical Research in Toxicology.
[14] J. Andersen,et al. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo , 2010, Neuroscience Letters.
[15] K. Marcelain,et al. Copper neurotoxicity is dependent on dopamine‐mediated copper uptake and one‐electron reduction of aminochrome in a rat substantia nigra neuronal cell line , 2001, Journal of neurochemistry.
[16] S. Ledoux,et al. Copper·Dopamine Complex Induces Mitochondrial Autophagy Preceding Caspase-independent Apoptotic Cell Death* , 2009, Journal of Biological Chemistry.
[17] S. Ledoux,et al. Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity. , 2010, Chemical research in toxicology.
[18] A. Grimaldi,et al. Autophagy in invertebrates: insights into development, regeneration and body remodeling. , 2008, Current pharmaceutical design.
[19] D. Rubinsztein,et al. The Itinerary of Autophagosomes: From Peripheral Formation to Kiss-and-Run Fusion with Lysosomes , 2008, Traffic.
[20] L. Zanatta,et al. Enzymatic dopamine peroxidation in substantia nigra of human brain. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[21] J. Segura-Aguilar,et al. On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase. , 1989, Chemico-biological interactions.
[22] N. Mizushima,et al. Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. , 2010, Seminars in cell & developmental biology.
[23] Michael Cascio,et al. Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells , 2009, Neurobiology of Disease.
[24] J. Segura-Aguilar,et al. Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. , 2005, Chemical Research in Toxicology.
[25] Steve D. M. Brown,et al. α-Synuclein impairs macroautophagy: implications for Parkinson’s disease , 2010, The Journal of cell biology.
[26] Peter T. Lansbury,et al. Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.
[27] C. Chu,et al. Role of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells , 2008, Journal of neurochemistry.
[28] K. Jellinger,et al. Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease. , 1996, Biochimica et biophysica acta.
[29] M. Cookson,et al. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress , 2011, Autophagy.
[30] C. Welch,et al. Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects. , 1998, Biochimica et biophysica acta.
[31] J. Trojanowski,et al. Reversible Inhibition of α-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations* , 2005, Journal of Biological Chemistry.
[32] D. Ross,et al. A Potential Role for Cyclized Quinones Derived from Dopamine, DOPA, and 3,4-Dihydroxyphenylacetic Acid in Proteasomal Inhibition , 2006, Molecular Pharmacology.
[33] E. Rosengren,et al. Detection of 5-S-cysteinyldopamine in human brain , 2005, Journal of Neural Transmission.
[34] C. Thompson,et al. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. , 2000, The Journal of pharmacology and experimental therapeutics.
[35] J. Segura-Aguilar,et al. Copper neurotoxicity in rat substantia nigra and striatum is dependent on DT-diaphorase inhibition. , 2008, Chemical research in toxicology.
[36] R. M. Rose,et al. Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem , 1988, Neuroscience.
[37] B. Mannervik,et al. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. , 1997, The Biochemical journal.
[38] R. Youle,et al. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.
[39] Alberto Gatti,et al. The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease , 2002, FEBS letters.
[40] H. Yang,et al. Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y , 2011, Neuroscience.
[41] D. Selkoe,et al. Dopamine covalently modifies and functionally inactivates parkin , 2005, Nature Medicine.
[42] J. Segura-Aguilar,et al. Autophagy protects against aminochrome-induced cell death in substantia nigra-derived cell line. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.
[43] Y. Akao,et al. Neuromelanin selectively induces apoptosis in dopaminergic SH‐SY5Y cells by deglutathionylation in mitochondria: involvement of the protein and melanin component , 2008, Journal of neurochemistry.
[44] J. Segura-Aguilar,et al. Superoxide dismutase and catalase enhance autoxidation during one-electron reduction of aminochrome by NADPH-cytochrome P-450 reductase. , 1995, Biochemical and molecular medicine.
[45] J. Segura-Aguilar,et al. Aminochrome Induces Disruption of Actin, Alpha-, and Beta-Tubulin Cytoskeleton Networks in Substantia-Nigra-Derived Cell Line , 2010, Neurotoxicity Research.
[46] P. Riederer,et al. Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease , 2009, Neurotoxicity Research.
[47] J. Segura-Aguilar,et al. Monoamine transporter inhibitors and norepinephrine reduce dopamine‐dependent iron toxicity in cells derived from the substantia nigra , 2005, Journal of neurochemistry.
[48] T. Hastings. Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase , 1995, Journal of neurochemistry.
[49] The dopamine metabolite aminochrome inhibits mitochondrial complex I and modifies the expression of iron transporters DMT1 and FPN1 , 2012, BioMetals.
[50] M. T. Herrero,et al. On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation , 2004, Neurobiology of Disease.
[51] B. Mannervik,et al. Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. , 2000, Biochemical and biophysical research communications.
[52] J. B. Justice,et al. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter , 2001, Journal of neurochemistry.
[53] D. Njus,et al. Stoichiometry of H+-linked dopamine transport in chromaffin granule ghosts. , 1981, Biochemistry.
[54] J. Segura-Aguilar. Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome. , 1996, Biochemical and molecular medicine.
[55] T. Myöhänen,et al. Distribution of catechol‐O‐methyltransferase (COMT) proteins and enzymatic activities in wild‐type and soluble COMT deficient mice , 2010, Journal of neurochemistry.
[56] C. Welch,et al. Human Class Mu Glutathione Transferases, in Particular Isoenzyme M2-2, Catalyze Detoxication of the Dopamine Metabolite Aminochrome* , 1997, The Journal of Biological Chemistry.
[57] Kostas Vekrellis,et al. Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells* , 2008, Journal of Biological Chemistry.
[58] D. Sulzer,et al. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease , 2009, Neurotoxicity Research.
[59] B. Xia,et al. Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease. , 1996, Chemical research in toxicology.
[60] K. Fujita,et al. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection. , 1984, Journal of chromatography.
[61] W. Whisler,et al. Catecholamine oxidation and ionization properties indicated from the H+ release, tritium exchange, and spectral changes which occur during ferricyanide oxidation. , 1968, Biochemistry.
[62] Peter T Lansbury,et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. , 2008, The Journal of clinical investigation.
[63] E. Rosengren,et al. The neuromelanin of the human substantia nigra. , 1991, Biochimica et biophysica acta.
[64] X. Breakefield,et al. Biochemistry and genetics of monoamine oxidase. , 1990, Pharmacology & therapeutics.
[65] B. Bergamasco,et al. Is neuromelanin changed in Parkinson’s disease? Investigations by magnetic spectroscopies , 2006, Journal of Neural Transmission.
[66] Xiongwei Zhu,et al. Parkinson’s disease‐associated DJ‐1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction , 2012, Journal of neurochemistry.
[67] J. Segura-Aguilar,et al. Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity. , 2012, Biochimica et biophysica acta.
[68] E. Jung,et al. Autophagy protects the rotenone-induced cell death in α-synuclein overexpressing SH-SY5Y cells , 2010, Neuroscience Letters.
[69] A. Napolitano,et al. Oxidation chemistry of catecholamines and neuronal degeneration: an update. , 2011, Current medicinal chemistry.
[70] M. Schultzberg,et al. Distribution of dt diaphorase in the rat brain: Biochemical and immunohistochemical studies , 1988, Neuroscience.
[71] J. Segura-Aguilar,et al. Protective Effects of Nicotine Against Aminochrome-Induced Toxicity in Substantia Nigra Derived Cells: Implications for Parkinson’s Disease , 2012, Neurotoxicity Research.
[72] K. Wada,et al. Aberrant Interaction between Parkinson Disease-associated Mutant UCH-L1 and the Lysosomal Receptor for Chaperone-mediated Autophagy* , 2008, Journal of Biological Chemistry.
[73] F. Fonnum,et al. Vesicular neurotransmitter transporters as targets for endogenous and exogenous toxic substances. , 2008, Annual review of pharmacology and toxicology.
[74] V. Faundez,et al. A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles , 2009, The Journal of Biological Chemistry.